Table 2.
The estimated infarction size between AAβ and NO-AAβ group
| The peak value of myocardial enzyme | Before PS match | p value | After PS match | p value | ||
|---|---|---|---|---|---|---|
| AAβ (n = 872) | NO-AAβ (n = 1833) | AAβ (n = 226) | NO-AAβ (n = 452) | |||
| pMyo (U/L) | 69.4 (33–172) | 75 (32.8–228) | 0.12 | 75.2 (30.1–184.5) | 75.9 (34.8–224.5) | 0.32 |
| pCK-MB (ng/mL) | 28.3 (6–105) | 47.9 (8.8–164) | < 0.001 | 31.9 (8.7–111) | 57 (10–164) | 0.02 |
| pcTnI (ng/mL) | 3.3 (0.64–11.0) | 5.1 (1.2–17.1) | < 0.001 | 3.0 (0.72–10.0) | 6.0 (1.4–21.1) | 0.002 |
AAβ ACEI/ARB/β-B, Myo myoglobin, CK-MB creatine kinase-myocardial band, cTnI cardiac troponin I, p peak value of
p values for comparisons between the two groups. Significance level was 0.05